Central Sensitization and Physical Activity in Adolescents With HSD/hEDS
NCT ID: NCT05633225
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2022-11-25
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this study is to better understand pain and its impact on function in the daily activities of adolescents with Hypermobility Spectrum Disorder and/or hypermobile Ehlers-Danlos Syndrome.
This study will explore the presence of the pain sensitivity status after physical exercise as well as movement behaviour in adolescents with HSD/hEDS compared to a healthy control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Injury Prevention Exercises on Performance and Neuromuscular Function
NCT03251404
Physiotherapy Program Effect on Musculoskeletal Dysfunctions in Young Football Players
NCT05798988
External Stressors Prior to Traumatic Knee Injury in Youth Athletes.
NCT04869566
Integrated Exercise Therapy Interventions on the Performance and Injury Prevention in Competitive Sports
NCT04384003
Musculoskeletal Pain Among E-sport Athletes
NCT03910517
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient-group
Ninety adolescents, 13-17 years of age Diagnosed with Hypermobility Spectrum Disorder or hypermobile Ehlers Danlos Syndrome.
Submax exercise test on a bicycle ergometer
To achieve exertion and not exhaustion, cycling will be stopped at 75% of the expected maximum heart rate (maximum heart rate of 220 beats per minute minus age) as a target value.
If the participant then indicated that they do not feel strained, the cycling will continue until the participant experienced an effort on Borg Rating of Perceived Exertion Scale scale of 15 (hard).
Control-group
Ninety adolescents, 13-17 years of age. Participants have to be pain free at time of investigation (NRS score \<3/10)
Submax exercise test on a bicycle ergometer
To achieve exertion and not exhaustion, cycling will be stopped at 75% of the expected maximum heart rate (maximum heart rate of 220 beats per minute minus age) as a target value.
If the participant then indicated that they do not feel strained, the cycling will continue until the participant experienced an effort on Borg Rating of Perceived Exertion Scale scale of 15 (hard).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Submax exercise test on a bicycle ergometer
To achieve exertion and not exhaustion, cycling will be stopped at 75% of the expected maximum heart rate (maximum heart rate of 220 beats per minute minus age) as a target value.
If the participant then indicated that they do not feel strained, the cycling will continue until the participant experienced an effort on Borg Rating of Perceived Exertion Scale scale of 15 (hard).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with HSD or hEDS
* Able to read and understand Swedish
* Healthy
* Pain free at time of investigation (Numerical Rating Scale score \<3/10).
Exclusion Criteria
* Other syndromes with hypermobility such as the Marfan syndrome, Osteogenesis Imperfecta or other types of EDS.
* Co-morbidity with neurological disorders
* Pregnancy and one year postpartum.
* Past or present signs of rheumatic, neurologic, musculoskeletal, metabolic diseases.
* Chronic pain.
13 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Göteborg University
OTHER
Vastra Gotaland Region
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elke Schubert Hjalmarsson
RPT, Head of the occupational therapy and physiotherapy unit for children
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mari Lundberg, Professor
Role: STUDY_DIRECTOR
University of Gothenborg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska University Hospital
Gothenburg, Region Västra Götaland, Sweden
Skaraborgs Hospital Skövde
Skövde, Region Västra Götaland, Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):148-157. doi: 10.1002/ajmg.c.31539. Epub 2017 Feb 1.
Schubert-Hjalmarsson E, Fridolfsson J, Arvidsson D, Borjesson M, Lundberg M. Exploring physical activity patterns in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos Syndrome. Pediatr Rheumatol Online J. 2025 Jul 8;23(1):69. doi: 10.1186/s12969-025-01124-0.
Related Links
Access external resources that provide additional context or updates about the study.
hEDS Diagnostic Checklist
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSaPhA-HSD/hEDS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.